Stockreport

Helix Acquisition prices $150M initial public offering [Seeking Alpha]

BridgeBio Oncology Therapeutics, Inc.  (BBOT) 
PDF The Company has granted the underwriters a 45-day option to purchase up to an additional 2.25M Class A ordinary shares at the initial public offering price. More on H [Read more]